Harkin Eyes Inspection Fees For Drug, Ingredient Manufacturers
This article was originally published in The Tan Sheet
Executive Summary
Sen. Tom Harkin is considering a fee on drug firms to pay for facility inspections.
You may also be interested in...
FDA Envisions International Focus Groups Navigating Globalization Issues
FDA could help create several international coalitions to carry out the agency’s globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
In Brief
Teva’s Marth talks up OTC deal with P&G
Supplement Industry Questions FDA's Calculations For Food Safety User Fees
Good manufacturing practice compliance becomes more critical for dietary supplement firms as FDA sets the first user fees to cover agency costs for follow-up inspections of facilities and imports and work on mandatory recalls.